Checking INBX unusual options activity helps you spot when traders are making outsized bets on Inhibrx Biosciences Inc before the broader market catches on. Inhibrx Biosciences Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor INBX unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching INBX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking INBX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and INBX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma.
The company was incorporated in 2024 and is based in La Jolla, California.
Catalysts rarely arrive without a footprint, and INBX unusual options activity is often where that footprint shows up first. Our scanner tracks Inhibrx Biosciences Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at INBX unusual options volume on the call side or chasing put sweeps, Inhibrx Biosciences Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
